secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001213900-23-043580
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity receives Nasdaq additional delisting basis for bid price non-compliance; panel to decide
--------------------------------------------------------------------------------

- Received Nasdaq letter on May 23, 2023 confirming failure to regain $1.00 minimum bid price by May 22, 2023 deadline.
- Bid price non-compliance will serve as an additional basis for delisting, considered by Hearings Panel.
- Panel heard Company's appeal on May 18, 2023 regarding stockholders' equity requirement non-compliance.
- Company will provide additional information to Panel by required timeframe to support continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023043580/0001213900-23-043580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023043580/ea179363-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-043580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer